Elysse A. Orchard

Preservation of forelimb function by UPF1 gene therapy in a rat model of TDP-43-induced motor paralysis

Kasey L. Jackson, Robert D. Dayton, Elysse A. Orchard et al. · Gene Therapy · 2014 · 75 citations · Full text

Signal Transduction, Upf1 Gene Therapy, Neuroprotection +7

Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene

L. Becks, Misty Prince, H. Burson et al. · BMC Cancer · 2010 · 70 citations · Full text

Expansive Gene Transfer in the Rat CNS Rapidly Produces Amyotrophic Lateral Sclerosis Relevant Sequelae When TDP-43 is Overexpressed

David B. Wang, Robert D. Dayton, Phillip P Henning et al. · Molecular Therapy · 2010 · 58 citations · Full text

Novel nanocomposite stent coating releasing resveratrol and quercetin reduces neointimal hyperplasia and promotes re-endothelialization

James J. Kleinedler, John D. Foley, Elysse A. Orchard et al. · Journal of Controlled Release · 2012 · 52 citations

Nanomedicine, Vascular Disease, Angiogenesis +11

Selective Forelimb Impairment in Rats Expressing a Pathological TDP-43 25 kDa C-terminal Fragment to Mimic Amyotrophic Lateral Sclerosis

Robert D. Dayton, Michael A. Gitcho, Elysse A. Orchard et al. · Molecular Therapy · 2013 · 41 citations · Full text

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Pathological Tdp-43 +11